Dis-Chem Pharmacies's EBIT per Share for the
six
months ended in Feb. 2026 was R0.90.
Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 was R2.27.
During the past 3 years, the average EBIT per Share Growth Rate was -35.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -51.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Dis-Chem Pharmacies's EBIT per Share or its related term are showing as below:
JSE:DCP'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -64.1 Med: 8.5 Max: 30.9
Current: -35.5
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Dis-Chem Pharmacies was 30.90% per year. The lowest was -64.10% per year. And the median was 8.50% per year.
JSE:DCP's 3-Year EBIT Growth Rate is ranked worse than 94.12% of 527
companies
in the Healthcare Providers & Services industry
Industry Median: 12.1
vs JSE:DCP: -35.50
Dis-Chem Pharmacies (JSE:DCP) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Dis-Chem Pharmacies EBIT per Share Related Terms
Dis-Chem Pharmacies EBIT per Share Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was R2.27
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies (JSE:DCP) has a EBIT per Share of R2.27 as of Feb. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Dis-Chem Pharmacies and its competitors. According to the industry distribution chart, Dis-Chem Pharmacies ranks #496 out of 527 companies in the Healthcare Providers & Services industry, placing it in the top 94.1%.
Is Dis-Chem Pharmacies' EBIT per Share too high?
Dis-Chem Pharmacies' current EBIT per Share is R2.27. Based on the distribution chart, Dis-Chem Pharmacies ranks #496 out of 527 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Dis-Chem Pharmacies has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' EBIT per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #496 out of 527 companies for EBIT per Share. This places Dis-Chem Pharmacies in the lower half of its industry. The industry median EBIT per Share is 12.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.10, based on 527 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Dis-Chem Pharmacies and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dis-Chem Pharmacies's current EBIT per Share is R2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.18, compared to a current price of R32.60 — trading 14.6% below its estimated fair value. The current EBIT per Share is R2.27. Dis-Chem Pharmacies' overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current EBIT per Share is R2.27 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R32.60 is trading 14.6% below its estimated GF Value™ of R38.18.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
EBIT per Share: R2.27
GF Value™: R38.18 vs. price of R32.60 (14.6% below fair value)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
85GF Score
Get the complete analysis for JSE:DCP
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
